Serum Institute joins Oxford and CEPI to speed up Bundibugyo Ebola vaccine as outbreak widens in DRC and Uganda.
Serum Institute of India has joined Oxford University and CEPI to accelerate the development of an experimental Bundibugyo Ebola vaccine as the outbreak expands in the Democratic Republic of Congo and Uganda.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near Democratic Republic of the Congo
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
UN warns women and girls face highest risk of Ebola infection in DR Congo, Uganda outbreak due to caregiving roles.
The UN has warned that women and girls face the highest risk of Ebola infection during the current outbreak in DR Congo and Uganda due to their caregiving and frontline roles.
WHO chief: Ebola risk assessment revised to 'very high' at national level, high regionally, low globally.
WHO chief is revising the Ebola risk assessment to very high at the national level, high at the regional level, and low at the global level.
EMA recommends Novo Nordisk's Wegovy oral pill for approval, first in new class of weight-loss drugs.
The European Medicines Agency recommended approval for Novo Nordisk's Wegovy pill, the first oral form of the new weight-loss drugs.
Nearly 1.2 billion people lived with mental disorders in 2023, double 1990 levels, making them the leading cause of disability globally, a Lancet study finds.
A new study published in The Lancet finds nearly 1.2 billion people worldwide had mental disorders in 2023, double the 1990 figure, making mental disorders the leading cause of disability globally.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.